1. The ‘early birds’: natural IgM antibodies and immune surveillance;Vollmers;Histol. Histopathol.,2005
2. Adjuvant therapy for gastric adenocarcinoma with the apoptosis-inducing human monoclonal antibody SC-1: first clinical and histopathological results;Vollmers;Oncol. Rep.,1998
3. Cysteine-rich fibroblast growth factor receptor 1, a new marker for precancerous epithelial lesions defined by the human monoclonal antibody PAM-1;Brandlein;Cancer Res.,2003
4. Phase I pilot clinical trial of human IgM monoclonal antibody to ganglioside GM3 in patients with metastatic melanoma;Irie;Cancer Immunol. Immun.,2004
5. Phase I trial of a novel human monoclonal antibody mAb216 in patients with relapsed or refractory B-cell acute lymphoblastic leukemia;Liedtke;Haematol-Hematol. J.,2012